Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $49.74 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $18.01 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $17.24 | 1 | $0 (2018) |
| Novo Nordisk Inc | $14.49 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $17.24 | 1 | Merck Sharp & Dohme Corporation ($17.24) |
| 2017 | $32.50 | 2 | GlaxoSmithKline, LLC. ($18.01) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2018 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: WOMENS HEALTH | ||||||
| 08/25/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 02/27/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 328 | 368 | $52,474 | $21,437 |
| 2022 | 3 | 344 | 391 | $51,206 | $24,537 |
| 2021 | 5 | 737 | 817 | $120,999 | $48,269 |
| 2020 | 8 | 1,048 | 1,195 | $166,833 | $56,317 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 278 | 316 | $47,757 | $20,013 | 41.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,369 | $1,328 | 30.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 29 | $348.00 | $96.08 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 291 | 336 | $46,082 | $22,058 | 47.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $4,776 | $2,381 | 49.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 27 | 29 | $348.00 | $96.96 | 27.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 595 | 668 | $104,588 | $41,644 | 39.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 61 | 61 | $11,141 | $4,224 | 37.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 16 | $3,025 | $1,698 | 56.1% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 12 | 12 | $1,525 | $493.90 | 32.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 55 | 60 | $720.00 | $208.80 | 29.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 765 | 907 | $133,354 | $44,664 | 33.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 63 | 63 | $11,269 | $4,235 | 37.6% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 56 | 56 | $6,652 | $2,661 | 40.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 29 | $5,397 | $2,456 | 45.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 39 | 39 | $3,597 | $1,213 | 33.7% |
| 12001 | Repair of wound (2.5 centimeters or less) of the scalp, neck, underarms, trunk, arms and/or legs | Office | 2020 | 13 | 13 | $5,215 | $499.85 | 9.6% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 22 | 22 | $557.00 | $359.37 | 64.5% |
| 81002 | Urinalysis, manual test | Office | 2020 | 61 | 66 | $792.00 | $228.49 | 28.8% |
About Dr. Chibuzo Emenari, MD
Dr. Chibuzo Emenari, MD is a Family Medicine healthcare provider based in Phillipsburg, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1659692887.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chibuzo Emenari, MD has received a total of $49.74 in payments from pharmaceutical and medical device companies, with $17.24 received in 2018. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($49.74).
As a Medicare-enrolled provider, Emenari has provided services to 2,457 Medicare beneficiaries, totaling 2,771 services with total Medicare billing of $150,560. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Phillipsburg, NJ
- Active Since 06/22/2010
- Last Updated 08/21/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659692887
Products in Payments
- ADVAIR (Drug) $18.01
- NEXPLANON (Drug) $17.24
- Victoza (Drug) $14.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Phillipsburg
Manasi Revankar, D.o, D.O
Family Medicine — Payments: $1,217
Dr. Ana Gomes, Do, Cmd, DO, CMD
Family Medicine — Payments: $590.76
Peter Sugarbaker
Family Medicine — Payments: $495.40
Frank Lombardi, Do, DO
Family Medicine — Payments: $338.19
Dr. Thaddeus Aversa, Do, DO
Family Medicine — Payments: $275.26
Ileana Ortiz-Evans, Md, MD
Family Medicine — Payments: $271.24